itraconazole has been researched along with naproxen in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Augustijns, P; Froyen, L; Humbeeck, JV; Martens, JA; Van den Mooter, G; Van Eerdenbrugh, B; Vermant, J | 1 |
| Backhuijs, F; Martens, JA; Van den Mooter, G; Vialpando, M | 1 |
| Barclay, ML; Begg, EJ; Moore, GA; Zhang, M | 1 |
| Bassand, C; Chavez, PF; Dodou, K; Meeus, J; Ousset, A; Robin, F; Schubert, MA; Somville, P | 1 |
| Chan, C; Ferrar, JA; Leung, DH; Sellers, BD | 1 |
| Bunjes, H; Czyz, S; Finke, JH; Juhnke, M; Kwade, A; van Eerdenbrugh, B; Wewers, M | 1 |
| Ito, S; Iwamoto, K; Kamimura, H; Mizunaga, M; Nakayama, K; Negoro, T; Nishiwaki, M; Nomura, Y; Suemizu, H; Yamazaki, H; Yoneda, N | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for itraconazole and naproxen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for itraconazole and naproxen
| Article | Year |
|---|---|
Solubility increases associated with crystalline drug nanoparticles: methodologies and significance.
Topics: Acetamides; Acetophenones; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Excipients; Itraconazole; Light; Micelles; Nanoparticles; Naproxen; Nephelometry and Turbidimetry; Particle Size; Phenytoin; Polyethylene Glycols; Scattering, Radiation; Solubility; Suspensions; Vitamin E | 2010 |
Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen.
Topics: Calorimetry, Differential Scanning; Carboxymethylcellulose Sodium; Excipients; Fenofibrate; Ibuprofen; Itraconazole; Naproxen; Particle Size; Porosity; Powders; Risk Assessment; Silicon Dioxide; Solubility; Temperature | 2012 |
A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.
Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Limit of Detection; Naproxen; Observer Variation; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2013 |
Development of a small-scale spray-drying approach for amorphous solid dispersions (ASDs) screening in early drug development.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Calorimetry, Differential Scanning; Crystallization; Desiccation; Drug Development; Itraconazole; Methylcellulose; Naproxen; Phase Transition; Polyethylene Glycols; Polymers; Polyvinyls; Solubility; Solvents | 2019 |
Towards an improved understanding of drug excipient interactions to enable rapid optimization of nanosuspension formulations.
Topics: Chemistry, Pharmaceutical; Excipients; Hydrophobic and Hydrophilic Interactions; Indomethacin; Itraconazole; Models, Molecular; Nanoparticles; Naproxen; Particle Size; Suspensions | 2020 |
Spray drying of API nanosuspensions: Importance of drying temperature, type and content of matrix former and particle size for successful formulation and process development.
Topics: Chemistry, Pharmaceutical; Desiccation; Itraconazole; Nanoparticles; Naproxen; Particle Size; Pharmaceutical Preparations; Pyrrolidines; Sodium Dodecyl Sulfate; Solubility; Spray Drying; Surface Properties; Suspensions; Technology, Pharmaceutical; Temperature; Vinyl Compounds | 2020 |
Predicted values for human total clearance of a variety of typical compounds with differently humanized-liver mouse plasma data.
Topics: Acetamides; Albuterol; Animals; Carbamates; Chromatography, Liquid; Diazepam; Diclofenac; Digitoxin; Humans; Itraconazole; Ketoprofen; Liver; Metabolic Clearance Rate; Mice; Mice, Transgenic; Naproxen; Pharmaceutical Preparations; Phenytoin; Piperidines; Pravastatin; Pyrimidines; Quinidine; Tandem Mass Spectrometry; Telmisartan; Terfenadine; Verapamil | 2020 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |